Nimotuzumab with chemoradiation confers a survival advantage in treatment-naïve head and neck tumors over expressing EGFR. (Q42474675)
Jump to navigation
Jump to search
scientific article published on October 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nimotuzumab with chemoradiation confers a survival advantage in treatment-naïve head and neck tumors over expressing EGFR. |
scientific article published on October 2010 |
Statements
1 reference
Nimotuzumab with chemoradiation confers a survival advantage in treatment-naïve head and neck tumors over expressing EGFR. (English)
1 reference
Chetana Basavaraj
1 reference
Patricia Sierra
1 reference
Jatteppanavar Shivu
1 reference
Ramakrishnan Melarkode
1 reference
Enrique Montero
1 reference
Pradip Nair
1 reference
1 October 2010
1 reference
1 reference
Identifiers
1 reference